DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

South Korea · Delayed Price · Currency is KRW

13,940

-210 (-1.48%)

At close: Apr 9, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Manufacturing Industry			105.15B	99.19B				79.98B	85.80B	81.96B
Pharmaceutical Manufacturing Industry Growth			6.00%	-				-6.78%	4.69%	13.53%
Pharmaceutical Wholesalers			22.55B	23.63B				19.70B	32.77B	62.83B
Pharmaceutical Wholesalers Growth			-4.56%	-				-39.89%	-47.84%	-8.64%
Medical Information System			285.59M	352.03M				612.27M	687.65M	865.79M
Medical Information System Growth			-18.88%	-				-10.96%	-20.58%	31.05%
Pharmaceutical Raw Materials Manufacturing			14.61B	13.80B				10.38B	7.83B	3.90B
Pharmaceutical Raw Materials Manufacturing Growth			5.84%	-				32.66%	100.61%	65.58%
Cosmetic and medical device manufacturing and sales			9.81B	8.99B				7.98B	1.93B	-
Cosmetic and medical device manufacturing and sales Growth			9.06%	-				313.65%	-	-
Unallocated Adjustment			-11.04B	-14.06B				-8.51B	-6.82B	-
Intersegment Revenue			-	-				-	-	-7.27B
Total			141.36B	131.91B				110.14B	122.20B	142.29B
Total Growth			7.16%	-				-9.87%	-14.12%	2.31%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
The Republic of Korea			128.63B	117.09B				98.54B	110.67B	138.08B
The Republic of Korea Growth			9.86%	-				-10.96%	-19.85%	2.77%
China			5.61M	3.62B				1.08B	4.01B	-
China Growth			-99.84%	-				-73.02%	-	-
Myanmar / Cambodia			2.12B	2.11B				2.34B	2.63B	1.62B
Myanmar / Cambodia Growth			0.59%	-				-10.77%	61.87%	-29.84%
Ecuador/Bolivia			1.09B	1.16B				-	-	-
Ecuador/Bolivia Growth			-6.58%	-				-	-	-
Germany			6.89B	5.03B				6.19B	2.19B	177.86M
Germany Growth			36.87%	-				182.31%	1132.06%	57.19%
Others			1.23B	2.27B				1.64B	1.93B	1.65B
Others Growth			-45.95%	-				-15.04%	17.03%	9.44%
Vietnam			1.41B	640.28M				353.34M	776.33M	766.33M
Vietnam Growth			119.61%	-				-54.49%	1.31%	-3.27%
Total			141.36B	131.91B				110.14B	122.20B	142.29B
Total Growth			7.16%	-				-9.87%	-14.12%	2.31%

Source: S&P Global Market Intelligence.